Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pycnogenol for Pigmentation Prevention After Sclerotherapy
NCT04203043Phase 2Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Hyperpigmentation comparing Pycnogenol with Placebo (2 arms). Primary endpoint: Photographic evaluation of the presence or absence of skin hyperpigmentation at 90 days. Status: unknown.
02
Drugs
grape seed extract
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on NCT04203043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203043.